Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Ribitol-phosphate: chemical tools to probe the biology of a unique mammalian carbohydrate

Project description

Study of faulty glycan could aid treatment of devastating muscle diseases

Proteins are the workhorses of cells, the building block of molecules for receptors, immunoglobulins, hormones and more. During or after translation, the majority of proteins are 'decorated' with carbohydrates in a process called glycosylation, a highly regulated process that affects their 3D structure, function, and stability. When it goes awry, malfunctioning proteins can play a role in disease processes. The EU-funded RibiTool project is investigating a unique cell-surface glycan whose faulty assembly results in the forms of congenital muscular dystrophy (muscle diseases characterised by progressive muscle degeneration) called α-dystroglycanopathies. Tools developed within the project will enable study of the assembly, structure and function of the glycan that could open the door to therapies for these devastating diseases.

Objective

Cell-surface proteins are decorated with a variety of different carbohydrate structures that play central roles in mammalian biology. The complex nature of glycan structures and the pathways by which they are assembled make it a challenging task to decipher their exact function in cells, knowledge that is essential if we are to understand how malfunctioning leads to disease. This proposal aims to deliver innovative approaches to probe a distinct pathway of glycosylation essential to mammalian biology and to use these strategies to provide novel insights into the mechanisms underlying normal cellular functioning and disease pathology. The work programme is built around a specific type of O-linked cell-surface glycan that carries two critical ribitol-phosphate (RboP) residues, unique carbohydrates that so far have not been identified in other mammalian glycoconjugates. Failure to correctly assemble this glycan causes a range of congenital muscular dystrophies known as α-dystroglycanopathies. Despite its importance in disease pathology, many aspects of RboP utilisation and functioning in mammalian cells are poorly understood. The proposed programme offers a powerful and original approach to address these key issues in cell biology by creating a set of novel chemical tools. These tools will enable the probing and manipulation of both RboP-carrying glycoconjugates as well as the enzymes responsible for installing RboP onto the glycans in a cellular context. Integration of these tools with fundamental 3-D structural information and studies in cellular models of α-dystroglycanopathy will offer the unprecedented opportunity to directly link genetic defects to molecular and cellular aspects of enzyme function and through to observed changes in glycosylation status. These pioneering strategies will impact our fundamental understanding of key processes in mammalian cells and will also enable the exploitation of this unique pathway for the design of therapeutic strategies.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2019-STG

See all projects funded under this call

Host institution

UNIVERSITY OF YORK
Net EU contribution
€ 1 494 411,00
Address
HESLINGTON
YO10 5DD YORK NORTH YORKSHIRE
United Kingdom
Region
Yorkshire and the Humber North Yorkshire York
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 494 411,00

Beneficiaries (1)